{
  "kb_version": "2.0.0-supplement",
  "reference_build": "GRCh37",
  "description": "Supplementary variants to merge with kb.json - brings total to 150+",
  "variants": [
    {
      "rsid": "rs1333049",
      "chr": "9",
      "pos": 22115503,
      "category": ["Health", "Cardiovascular"],
      "gene": "CDKN2B-AS1",
      "trait": "Myocardial Infarction Risk (9p21)",
      "risk_model": {"type": "allele_dose", "risk_allele": "C", "per_allele_or": 1.29},
      "interpretation": {"plain_language": "Additional 9p21 variant associated with myocardial infarction and coronary artery disease risk.", "limitations": ["Mechanism involves non-coding RNA regulation", "Risk independent of traditional cardiovascular risk factors"]},
      "evidence": [{"pmid": "17554300", "study_type": "GWAS", "n": 22000, "replicated": true}, {"pmid": "18262040", "study_type": "Meta-analysis", "n": 38000, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs3798220",
      "chr": "6",
      "pos": 160961137,
      "category": ["Health", "Cardiovascular"],
      "gene": "LPA",
      "trait": "Lipoprotein(a) & CAD Risk",
      "risk_model": {"type": "allele_dose", "risk_allele": "C", "per_allele_or": 2.57},
      "interpretation": {"plain_language": "Strong LPA variant associated with very high Lp(a) levels and significantly increased coronary artery disease risk.", "limitations": ["Lp(a) measurement recommended", "Limited therapeutic options currently"]},
      "evidence": [{"pmid": "19198609", "study_type": "GWAS", "n": 5000, "replicated": true}, {"pmid": "24560231", "study_type": "Meta-analysis", "n": 120000, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs11206510",
      "chr": "1",
      "pos": 55496039,
      "category": ["Health", "Cardiovascular"],
      "gene": "PCSK9",
      "trait": "LDL Cholesterol Levels",
      "risk_model": {"type": "allele_dose", "risk_allele": "T", "per_allele_or": 1.15},
      "interpretation": {"plain_language": "PCSK9 variant affecting LDL receptor degradation. PCSK9 inhibitors are a major class of cholesterol-lowering drugs.", "limitations": ["May influence response to PCSK9 inhibitor therapy"]},
      "evidence": [{"pmid": "17295865", "study_type": "GWAS", "n": 15000, "replicated": true}, {"pmid": "24970784", "study_type": "Clinical trial", "n": 18000, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs1746048",
      "chr": "10",
      "pos": 44751277,
      "category": ["Health", "Cardiovascular"],
      "gene": "CXCL12",
      "trait": "Coronary Artery Disease (CXCL12)",
      "risk_model": {"type": "allele_dose", "risk_allele": "C", "per_allele_or": 1.17},
      "interpretation": {"plain_language": "CXCL12 variant associated with coronary artery disease risk through inflammatory pathways.", "limitations": ["Effect modest", "Part of polygenic risk"]},
      "evidence": [{"pmid": "17478679", "study_type": "GWAS", "n": 23000, "replicated": true}],
      "confidence": "Moderate"
    },
    {
      "rsid": "rs2383206",
      "chr": "9",
      "pos": 22115503,
      "category": ["Health", "Cardiovascular"],
      "gene": "9p21",
      "trait": "Coronary Artery Disease (9p21)",
      "risk_model": {"type": "allele_dose", "risk_allele": "G", "per_allele_or": 1.26},
      "interpretation": {"plain_language": "Additional 9p21 locus variant contributing to coronary artery disease risk.", "limitations": ["In LD with other 9p21 variants"]},
      "evidence": [{"pmid": "17554300", "study_type": "GWAS", "n": 22000, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs1800790",
      "chr": "4",
      "pos": 154587884,
      "category": ["Health", "Cardiovascular"],
      "gene": "FGB",
      "trait": "Fibrinogen Levels",
      "risk_model": {"type": "allele_dose", "risk_allele": "A", "per_allele_or": 1.3},
      "interpretation": {"plain_language": "Beta-fibrinogen variant associated with elevated fibrinogen levels and increased thrombotic risk.", "limitations": ["Clinical significance for thrombosis modest"]},
      "evidence": [{"pmid": "10521366", "study_type": "Association study", "n": 3000, "replicated": true}],
      "confidence": "Moderate"
    },
    {
      "rsid": "rs5918",
      "chr": "17",
      "pos": 45360730,
      "category": ["Health", "Cardiovascular", "Pharmacogenomics"],
      "gene": "ITGB3",
      "trait": "Platelet Aggregation (PlA2)",
      "risk_model": {"type": "allele_dose", "risk_allele": "C", "per_allele_or": 1.3},
      "interpretation": {"plain_language": "Platelet glycoprotein IIIa variant associated with increased platelet aggregation and potentially reduced aspirin response.", "limitations": ["May affect antiplatelet therapy efficacy", "Clinical implementation limited"]},
      "evidence": [{"pmid": "8571947", "study_type": "Association study", "n": 2000, "replicated": true}],
      "confidence": "Moderate"
    },
    {
      "rsid": "rs662",
      "chr": "7",
      "pos": 95308134,
      "category": ["Health", "Cardiovascular"],
      "gene": "PON1",
      "trait": "Antioxidant Capacity (Q192R)",
      "risk_model": {"type": "genotype_category", "categories": {"AA": {"label": "QQ - Higher paraoxonase activity"}, "AG": {"label": "QR - Intermediate"}, "GG": {"label": "RR - Lower paraoxonase activity"}}},
      "interpretation": {"plain_language": "Paraoxonase 1 variant affecting HDL antioxidant function and organophosphate metabolism.", "limitations": ["Functional significance depends on substrate"]},
      "evidence": [{"pmid": "9603939", "study_type": "Association study", "n": 1500, "replicated": true}],
      "confidence": "Moderate"
    },
    {
      "rsid": "rs1805124",
      "chr": "3",
      "pos": 38620424,
      "category": ["Health", "Cardiovascular"],
      "gene": "SCN5A",
      "trait": "Cardiac Arrhythmia Risk",
      "risk_model": {"type": "allele_dose", "risk_allele": "A", "per_allele_or": 1.5},
      "interpretation": {"plain_language": "Sodium channel variant associated with cardiac conduction abnormalities and arrhythmia susceptibility.", "limitations": ["ECG screening may be warranted if symptomatic", "Avoid QT-prolonging medications"]},
      "evidence": [{"pmid": "11809893", "study_type": "Association study", "n": 1000, "replicated": true}],
      "confidence": "Moderate"
    },
    {
      "rsid": "rs16891982",
      "chr": "5",
      "pos": 33958959,
      "category": ["Traits", "Physical"],
      "gene": "SLC45A2",
      "trait": "Skin/Hair Pigmentation",
      "risk_model": {"type": "genotype_category", "categories": {"CC": {"label": "Lighter skin/hair"}, "CG": {"label": "Intermediate"}, "GG": {"label": "Darker pigmentation"}}},
      "interpretation": {"plain_language": "SLC45A2 variant affecting melanin synthesis and skin/hair pigmentation.", "limitations": ["Multiple genes contribute to pigmentation"]},
      "evidence": [{"pmid": "16357254", "study_type": "Association study", "n": 2000, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs1805008",
      "chr": "16",
      "pos": 89919746,
      "category": ["Traits", "Physical", "Health"],
      "gene": "MC1R",
      "trait": "Red Hair Variant (R160W)",
      "risk_model": {"type": "allele_dose", "risk_allele": "T", "per_allele_or": 2.2},
      "interpretation": {"plain_language": "MC1R variant associated with red hair phenotype and increased melanoma risk.", "limitations": ["Sun protection important for carriers"]},
      "evidence": [{"pmid": "8872461", "study_type": "Association study", "n": 500, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs1805009",
      "chr": "16",
      "pos": 89920138,
      "category": ["Traits", "Physical", "Health"],
      "gene": "MC1R",
      "trait": "Red Hair Variant (D294H)",
      "risk_model": {"type": "allele_dose", "risk_allele": "C", "per_allele_or": 2.0},
      "interpretation": {"plain_language": "Another MC1R variant contributing to red hair/fair skin phenotype.", "limitations": ["Multiple MC1R variants typically needed for red hair phenotype"]},
      "evidence": [{"pmid": "8872461", "study_type": "Association study", "n": 500, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs12821256",
      "chr": "12",
      "pos": 89328335,
      "category": ["Traits", "Physical"],
      "gene": "KITLG",
      "trait": "Blonde Hair",
      "risk_model": {"type": "genotype_category", "categories": {"CC": {"label": "Associated with blonde hair"}, "CT": {"label": "Partial effect"}, "TT": {"label": "Darker hair likely"}}},
      "interpretation": {"plain_language": "KITLG variant associated with blonde hair color in Europeans.", "limitations": ["Hair color determined by many genes"]},
      "evidence": [{"pmid": "18488028", "study_type": "GWAS", "n": 5000, "replicated": true}],
      "confidence": "Moderate"
    },
    {
      "rsid": "rs182549",
      "chr": "2",
      "pos": 136545028,
      "category": ["Traits", "Nutrigenomics"],
      "gene": "MCM6",
      "trait": "Lactose Tolerance (European)",
      "risk_model": {"type": "genotype_category", "categories": {"TT": {"label": "Lactose tolerant"}, "CT": {"label": "Intermediate"}, "CC": {"label": "Lactose intolerant"}}},
      "interpretation": {"plain_language": "European lactase persistence variant in strong LD with rs4988235.", "limitations": ["Same functional effect as rs4988235"]},
      "evidence": [{"pmid": "14647206", "study_type": "Association study", "n": 230, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs4341",
      "chr": "17",
      "pos": 63477061,
      "category": ["Traits", "Athletic"],
      "gene": "ACE",
      "trait": "Endurance Performance (ACE I/D proxy)",
      "risk_model": {"type": "genotype_category", "categories": {"GG": {"label": "II genotype proxy - endurance advantage"}, "CG": {"label": "ID genotype proxy - balanced"}, "CC": {"label": "DD genotype proxy - power/strength advantage"}}},
      "interpretation": {"plain_language": "ACE I/D polymorphism associated with endurance (I) vs power (D) athletic performance.", "limitations": ["Athletic performance determined by many factors", "Effect sizes modest"]},
      "evidence": [{"pmid": "10694870", "study_type": "Association study", "n": 1000, "replicated": true}],
      "confidence": "Moderate"
    },
    {
      "rsid": "rs1800012",
      "chr": "17",
      "pos": 50200388,
      "category": ["Traits", "Athletic", "Health"],
      "gene": "COL1A1",
      "trait": "Tendon/Ligament Injury Risk",
      "risk_model": {"type": "genotype_category", "categories": {"GG": {"label": "Lower injury risk"}, "GT": {"label": "Intermediate"}, "TT": {"label": "Increased soft tissue injury risk"}}},
      "interpretation": {"plain_language": "Collagen type I variant associated with Achilles tendon and ACL injury susceptibility.", "limitations": ["Proper training and conditioning more important than genetics"]},
      "evidence": [{"pmid": "15930086", "study_type": "Association study", "n": 500, "replicated": true}],
      "confidence": "Moderate"
    },
    {
      "rsid": "rs1726866",
      "chr": "7",
      "pos": 141972905,
      "category": ["Traits", "Taste"],
      "gene": "TAS2R38",
      "trait": "Bitter Taste (V262A)",
      "risk_model": {"type": "genotype_category", "categories": {"CC": {"label": "Non-taster haplotype"}, "CT": {"label": "Medium taster"}, "TT": {"label": "Strong taster haplotype"}}},
      "interpretation": {"plain_language": "Part of the TAS2R38 haplotype determining bitter taste perception (PAV vs AVI).", "limitations": ["Combined with other TAS2R38 SNPs for phenotype prediction"]},
      "evidence": [{"pmid": "12595690", "study_type": "Association study", "n": 1000, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs4481887",
      "chr": "1",
      "pos": 68449451,
      "category": ["Traits", "Sensory"],
      "gene": "OR2M7",
      "trait": "Asparagus Urine Smell Detection",
      "risk_model": {"type": "genotype_category", "categories": {"AA": {"label": "Unable to smell asparagus metabolites"}, "AG": {"label": "Partial ability"}, "GG": {"label": "Can detect asparagus metabolite smell"}}},
      "interpretation": {"plain_language": "Olfactory receptor variant determining ability to detect asparagus metabolites in urine.", "limitations": ["No health implications", "Interesting trait variant"]},
      "evidence": [{"pmid": "27741223", "study_type": "GWAS", "n": 6900, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs7495174",
      "chr": "15",
      "pos": 28344238,
      "category": ["Traits", "Physical"],
      "gene": "OCA2",
      "trait": "Green/Hazel Eyes",
      "risk_model": {"type": "genotype_category", "categories": {"AA": {"label": "More likely green/hazel"}, "AG": {"label": "Variable"}, "GG": {"label": "Brown more likely"}}},
      "interpretation": {"plain_language": "OCA2 haplotype variant contributing to eye color variation, particularly green/hazel eyes.", "limitations": ["Eye color is polygenic"]},
      "evidence": [{"pmid": "18172693", "study_type": "Association study", "n": 3000, "replicated": true}],
      "confidence": "Moderate"
    },
    {
      "rsid": "rs1393350",
      "chr": "6",
      "pos": 396321,
      "category": ["Traits", "Physical"],
      "gene": "TYR",
      "trait": "Freckling",
      "risk_model": {"type": "genotype_category", "categories": {"AA": {"label": "Less freckling"}, "GA": {"label": "Moderate freckling"}, "GG": {"label": "More freckling"}}},
      "interpretation": {"plain_language": "Tyrosinase variant associated with freckling tendency.", "limitations": ["Sun exposure also affects freckling"]},
      "evidence": [{"pmid": "18488028", "study_type": "GWAS", "n": 5000, "replicated": true}],
      "confidence": "Moderate"
    },
    {
      "rsid": "rs2228479",
      "chr": "1",
      "pos": 152285861,
      "category": ["Traits", "Physical"],
      "gene": "MC1R",
      "trait": "Hair Color/Skin Type",
      "risk_model": {"type": "genotype_category", "categories": {"AA": {"label": "Typical pigmentation"}, "AG": {"label": "Partial effect"}, "GG": {"label": "May contribute to fair features"}}},
      "interpretation": {"plain_language": "MC1R V92M variant with modest effect on pigmentation.", "limitations": ["Weaker effect than other MC1R variants"]},
      "evidence": [{"pmid": "8872461", "study_type": "Association study", "n": 500, "replicated": true}],
      "confidence": "Moderate"
    },
    {
      "rsid": "rs11803731",
      "chr": "2",
      "pos": 108972867,
      "category": ["Traits", "Physical"],
      "gene": "EDAR",
      "trait": "Hair Thickness",
      "risk_model": {"type": "genotype_category", "categories": {"TT": {"label": "Thicker hair (common in East Asians)"}, "AT": {"label": "Intermediate"}, "AA": {"label": "Typical thickness"}}},
      "interpretation": {"plain_language": "EDAR variant affecting hair thickness and other ectodermal traits.", "limitations": ["More common in East Asian populations"]},
      "evidence": [{"pmid": "18515362", "study_type": "Association study", "n": 2000, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs3827760",
      "chr": "2",
      "pos": 108973688,
      "category": ["Traits", "Physical"],
      "gene": "EDAR",
      "trait": "Hair Thickness & Tooth Shape (V370A)",
      "risk_model": {"type": "genotype_category", "categories": {"AA": {"label": "Thicker hair, shovel-shaped incisors"}, "AG": {"label": "Intermediate"}, "GG": {"label": "Typical features"}}},
      "interpretation": {"plain_language": "EDAR V370A affects multiple ectodermal traits including hair thickness, sweat gland density, and tooth morphology.", "limitations": ["Highly population-specific (East Asian)"]},
      "evidence": [{"pmid": "18515362", "study_type": "Association study", "n": 2000, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs17646946",
      "chr": "X",
      "pos": 66763873,
      "category": ["Traits", "Physical"],
      "gene": "AR",
      "trait": "Male Pattern Baldness",
      "risk_model": {"type": "allele_dose", "risk_allele": "G", "per_allele_or": 1.6},
      "interpretation": {"plain_language": "Androgen receptor variant associated with male pattern baldness.", "limitations": ["X-linked inheritance pattern", "Multiple genes affect baldness"]},
      "evidence": [{"pmid": "17952075", "study_type": "GWAS", "n": 5000, "replicated": true}],
      "confidence": "Moderate"
    },
    {
      "rsid": "rs6152",
      "chr": "X",
      "pos": 66763760,
      "category": ["Traits", "Physical"],
      "gene": "AR",
      "trait": "Male Pattern Baldness",
      "risk_model": {"type": "genotype_category", "categories": {"A": {"label": "Higher baldness risk"}, "G": {"label": "Lower baldness risk"}}},
      "interpretation": {"plain_language": "Additional androgen receptor variant contributing to baldness susceptibility.", "limitations": ["Hemizygous in males"]},
      "evidence": [{"pmid": "17952075", "study_type": "GWAS", "n": 5000, "replicated": true}],
      "confidence": "Moderate"
    },
    {
      "rsid": "rs2180439",
      "chr": "2",
      "pos": 223143198,
      "category": ["Traits", "Physical"],
      "gene": "PAX3",
      "trait": "Unibrow Tendency",
      "risk_model": {"type": "genotype_category", "categories": {"CC": {"label": "More likely unibrow"}, "CT": {"label": "Intermediate"}, "TT": {"label": "Less likely"}}},
      "interpretation": {"plain_language": "PAX3 variant associated with eyebrow hair pattern.", "limitations": ["Cosmetic trait only"]},
      "evidence": [{"pmid": "26926045", "study_type": "GWAS", "n": 6000, "replicated": true}],
      "confidence": "Moderate"
    },
    {
      "rsid": "rs1229984",
      "chr": "4",
      "pos": 99318162,
      "category": ["Traits", "Metabolic"],
      "gene": "ADH1B",
      "trait": "Alcohol Metabolism",
      "risk_model": {"type": "genotype_category", "categories": {"CC": {"label": "Rapid metabolism (protective against alcoholism)"}, "CT": {"label": "Intermediate"}, "TT": {"label": "Slower metabolism"}}},
      "interpretation": {"plain_language": "ADH1B*2 variant causes rapid alcohol metabolism, creating unpleasant effects that protect against alcohol use disorder.", "limitations": ["Protective effect well-established", "Common in East Asian populations"]},
      "evidence": [{"pmid": "16385451", "study_type": "Meta-analysis", "n": 15000, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs2254298",
      "chr": "3",
      "pos": 8773349,
      "category": ["Traits", "Behavioral"],
      "gene": "OXTR",
      "trait": "Social Anxiety & Attachment",
      "risk_model": {"type": "genotype_category", "categories": {"AA": {"label": "Higher social anxiety tendency"}, "AG": {"label": "Intermediate"}, "GG": {"label": "Lower social anxiety tendency"}}},
      "interpretation": {"plain_language": "Oxytocin receptor variant associated with social anxiety and attachment style.", "limitations": ["Behavioral genetics explains only fraction of variance", "Environment is crucial"]},
      "evidence": [{"pmid": "19706216", "study_type": "Association study", "n": 200, "replicated": true}],
      "confidence": "Low"
    },
    {
      "rsid": "rs1800955",
      "chr": "11",
      "pos": 637380,
      "category": ["Traits", "Behavioral"],
      "gene": "DRD4",
      "trait": "Novelty Seeking",
      "risk_model": {"type": "genotype_category", "categories": {"CC": {"label": "Lower novelty seeking"}, "CT": {"label": "Moderate"}, "TT": {"label": "Higher novelty seeking, more exploratory"}}},
      "interpretation": {"plain_language": "DRD4 promoter variant associated with novelty-seeking personality trait.", "limitations": ["Effect sizes small", "Personality is highly polygenic and environmental"]},
      "evidence": [{"pmid": "9732086", "study_type": "Association study", "n": 500, "replicated": true}],
      "confidence": "Low"
    },
    {
      "rsid": "rs25531",
      "chr": "17",
      "pos": 30237328,
      "category": ["Traits", "Behavioral"],
      "gene": "SLC6A4",
      "trait": "Serotonin Transporter",
      "risk_model": {"type": "genotype_category", "categories": {"AA": {"label": "Long allele - more stress resilient"}, "AG": {"label": "Intermediate"}, "GG": {"label": "Short allele - more reactive to environment"}}},
      "interpretation": {"plain_language": "5-HTTLPR functional variant affecting serotonin transporter expression. 'Short' allele carriers may be more susceptible to environmental influences (both positive and negative).", "limitations": ["Gene x environment interaction", "Replications inconsistent", "Not deterministic"]},
      "evidence": [{"pmid": "12869766", "study_type": "Association study", "n": 800, "replicated": true}],
      "confidence": "Low"
    },
    {
      "rsid": "rs6311",
      "chr": "13",
      "pos": 46897343,
      "category": ["Traits", "Behavioral"],
      "gene": "HTR2A",
      "trait": "Serotonin Receptor (5-HT2A)",
      "risk_model": {"type": "genotype_category", "categories": {"CC": {"label": "May affect serotonin signaling"}, "CT": {"label": "Intermediate"}, "TT": {"label": "Reference type"}}},
      "interpretation": {"plain_language": "Serotonin 2A receptor variant potentially affecting mood and antidepressant response.", "limitations": ["Clinical significance unclear", "Many factors affect mood"]},
      "evidence": [{"pmid": "15741923", "study_type": "Association study", "n": 500, "replicated": true}],
      "confidence": "Low"
    },
    {
      "rsid": "rs1006737",
      "chr": "12",
      "pos": 2345295,
      "category": ["Traits", "Behavioral", "Health"],
      "gene": "CACNA1C",
      "trait": "Mood Regulation",
      "risk_model": {"type": "allele_dose", "risk_allele": "A", "per_allele_or": 1.2},
      "interpretation": {"plain_language": "Voltage-gated calcium channel variant associated with bipolar disorder and other mood conditions.", "limitations": ["Effect size modest", "Not diagnostic"]},
      "evidence": [{"pmid": "18711365", "study_type": "GWAS", "n": 10000, "replicated": true}],
      "confidence": "Moderate"
    },
    {
      "rsid": "rs4570625",
      "chr": "12",
      "pos": 72378133,
      "category": ["Traits", "Behavioral"],
      "gene": "TPH2",
      "trait": "Impulsivity & Anxiety",
      "risk_model": {"type": "genotype_category", "categories": {"GG": {"label": "Higher amygdala reactivity"}, "GT": {"label": "Intermediate"}, "TT": {"label": "Lower amygdala reactivity"}}},
      "interpretation": {"plain_language": "Tryptophan hydroxylase 2 variant affecting serotonin synthesis in the brain.", "limitations": ["Behavioral genetics is complex", "Not deterministic"]},
      "evidence": [{"pmid": "16650386", "study_type": "Association study", "n": 300, "replicated": true}],
      "confidence": "Low"
    },
    {
      "rsid": "rs1800532",
      "chr": "11",
      "pos": 18026269,
      "category": ["Traits", "Behavioral"],
      "gene": "TPH1",
      "trait": "Sleep & Mood",
      "risk_model": {"type": "genotype_category", "categories": {"AA": {"label": "May affect peripheral serotonin"}, "AC": {"label": "Intermediate"}, "CC": {"label": "Reference type"}}},
      "interpretation": {"plain_language": "Tryptophan hydroxylase 1 variant affecting peripheral serotonin synthesis.", "limitations": ["TPH1 primarily peripheral, not CNS", "Clinical significance limited"]},
      "evidence": [{"pmid": "9878244", "study_type": "Association study", "n": 200, "replicated": true}],
      "confidence": "Low"
    },
    {
      "rsid": "rs492602",
      "chr": "19",
      "pos": 49206985,
      "category": ["Health", "Nutrigenomics"],
      "gene": "FUT2",
      "trait": "Secretor Status & Gut Microbiome",
      "risk_model": {"type": "genotype_category", "categories": {"GG": {"label": "Non-secretor"}, "AG": {"label": "Secretor"}, "AA": {"label": "Secretor"}}},
      "interpretation": {"plain_language": "FUT2 secretor status affects gut microbiome composition, B12 absorption, and susceptibility to certain infections.", "limitations": ["Non-secretors resistant to norovirus", "May have lower B12 levels"]},
      "evidence": [{"pmid": "21102463", "study_type": "GWAS", "n": 5000, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs10741657",
      "chr": "11",
      "pos": 14914878,
      "category": ["Health", "Nutrigenomics"],
      "gene": "CYP2R1",
      "trait": "Vitamin D Synthesis",
      "risk_model": {"type": "allele_dose", "risk_allele": "A", "per_allele_or": 1.3},
      "interpretation": {"plain_language": "CYP2R1 variant affecting 25-hydroxylation of vitamin D.", "limitations": ["Sun exposure and supplementation more important than genetics"]},
      "evidence": [{"pmid": "20541252", "study_type": "GWAS", "n": 33000, "replicated": true}],
      "confidence": "Moderate"
    },
    {
      "rsid": "rs12785878",
      "chr": "11",
      "pos": 71167449,
      "category": ["Health", "Nutrigenomics"],
      "gene": "DHCR7",
      "trait": "Vitamin D Levels",
      "risk_model": {"type": "allele_dose", "risk_allele": "G", "per_allele_or": 1.2},
      "interpretation": {"plain_language": "DHCR7 variant affecting vitamin D3 synthesis from 7-dehydrocholesterol.", "limitations": ["Testing vitamin D levels more informative than genotype"]},
      "evidence": [{"pmid": "20541252", "study_type": "GWAS", "n": 33000, "replicated": true}],
      "confidence": "Moderate"
    },
    {
      "rsid": "rs234706",
      "chr": "21",
      "pos": 43053551,
      "category": ["Health", "Nutrigenomics"],
      "gene": "CBS",
      "trait": "Homocysteine Metabolism (CBS C699T)",
      "risk_model": {"type": "genotype_category", "categories": {"AA": {"label": "Increased CBS activity"}, "AG": {"label": "Intermediate"}, "GG": {"label": "Normal activity"}}},
      "interpretation": {"plain_language": "Cystathionine beta-synthase variant affecting homocysteine metabolism and transsulfuration pathway.", "limitations": ["Upregulating variant", "May deplete homocysteine faster"]},
      "evidence": [{"pmid": "12042254", "study_type": "Association study", "n": 500, "replicated": true}],
      "confidence": "Low"
    },
    {
      "rsid": "rs7946",
      "chr": "17",
      "pos": 17476156,
      "category": ["Health", "Nutrigenomics"],
      "gene": "PEMT",
      "trait": "Choline Requirements",
      "risk_model": {"type": "genotype_category", "categories": {"TT": {"label": "Higher choline requirements (especially women)"}, "CT": {"label": "Moderately increased"}, "CC": {"label": "Normal choline needs"}}},
      "interpretation": {"plain_language": "PEMT variant affecting endogenous choline synthesis. Women with this variant may be more susceptible to choline deficiency.", "limitations": ["Effect more pronounced in premenopausal women", "Dietary choline intake important"]},
      "evidence": [{"pmid": "17522620", "study_type": "Intervention study", "n": 60, "replicated": true}],
      "confidence": "Moderate"
    },
    {
      "rsid": "rs12325817",
      "chr": "17",
      "pos": 17466884,
      "category": ["Health", "Nutrigenomics"],
      "gene": "PEMT",
      "trait": "Choline Metabolism",
      "risk_model": {"type": "genotype_category", "categories": {"CC": {"label": "Increased choline requirements"}, "CT": {"label": "Intermediate"}, "TT": {"label": "Normal requirements"}}},
      "interpretation": {"plain_language": "Additional PEMT variant affecting choline synthesis capacity.", "limitations": ["Eggs and liver are good dietary choline sources"]},
      "evidence": [{"pmid": "17522620", "study_type": "Intervention study", "n": 60, "replicated": true}],
      "confidence": "Moderate"
    },
    {
      "rsid": "rs855791",
      "chr": "22",
      "pos": 37469591,
      "category": ["Health", "Nutrigenomics"],
      "gene": "TMPRSS6",
      "trait": "Iron Regulation",
      "risk_model": {"type": "allele_dose", "risk_allele": "T", "per_allele_or": 1.3},
      "interpretation": {"plain_language": "TMPRSS6 variant affecting iron-regulatory hormone hepcidin, associated with lower iron and hemoglobin levels.", "limitations": ["May contribute to iron deficiency anemia risk", "Iron status testing recommended"]},
      "evidence": [{"pmid": "19696891", "study_type": "GWAS", "n": 50000, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs5082",
      "chr": "1",
      "pos": 116206406,
      "category": ["Health", "Nutrigenomics"],
      "gene": "APOA2",
      "trait": "Saturated Fat & Weight",
      "risk_model": {"type": "genotype_category", "categories": {"CC": {"label": "High saturated fat intake may increase BMI and reduce HDL"}, "CT": {"label": "Moderate effect"}, "TT": {"label": "Less affected by saturated fat"}}},
      "interpretation": {"plain_language": "APOA2 variant affecting response to dietary saturated fat. CC genotype individuals may benefit more from saturated fat restriction.", "limitations": ["Gene-diet interaction", "Overall diet quality more important"]},
      "evidence": [{"pmid": "19211821", "study_type": "Intervention study", "n": 3000, "replicated": true}],
      "confidence": "Moderate"
    },
    {
      "rsid": "rs1761667",
      "chr": "7",
      "pos": 80302418,
      "category": ["Health", "Nutrigenomics", "Traits"],
      "gene": "CD36",
      "trait": "Fat Taste Sensitivity",
      "risk_model": {"type": "genotype_category", "categories": {"AA": {"label": "Lower fat taste sensitivity"}, "AG": {"label": "Moderate"}, "GG": {"label": "Normal fat taste perception"}}},
      "interpretation": {"plain_language": "CD36 variant affecting oral fat sensing. Lower sensitivity may lead to overconsumption of fatty foods.", "limitations": ["One factor in fat preference", "Mindful eating can overcome"]},
      "evidence": [{"pmid": "22570613", "study_type": "Association study", "n": 300, "replicated": true}],
      "confidence": "Low"
    },
    {
      "rsid": "rs1535",
      "chr": "11",
      "pos": 61595564,
      "category": ["Health", "Nutrigenomics"],
      "gene": "FADS2",
      "trait": "Omega-6/Omega-3 Balance",
      "risk_model": {"type": "allele_dose", "risk_allele": "A", "per_allele_or": 1.15},
      "interpretation": {"plain_language": "FADS2 variant affecting desaturase activity and conversion of essential fatty acids.", "limitations": ["Direct EPA/DHA intake bypasses conversion limitation"]},
      "evidence": [{"pmid": "21829377", "study_type": "GWAS", "n": 8866, "replicated": true}],
      "confidence": "Moderate"
    },
    {
      "rsid": "rs1801394",
      "chr": "5",
      "pos": 7901501,
      "category": ["Health", "Nutrigenomics"],
      "gene": "MTRR",
      "trait": "B12 & Folate Metabolism (A66G)",
      "risk_model": {"type": "genotype_category", "categories": {"GG": {"label": "Reduced methionine synthase reductase activity"}, "AG": {"label": "Intermediate"}, "AA": {"label": "Normal function"}}},
      "interpretation": {"plain_language": "MTRR variant affecting vitamin B12 utilization and homocysteine metabolism.", "limitations": ["Compound effects with MTHFR variants", "B12 and folate supplementation can help"]},
      "evidence": [{"pmid": "12023983", "study_type": "Association study", "n": 500, "replicated": true}],
      "confidence": "Moderate"
    },
    {
      "rsid": "rs763361",
      "chr": "18",
      "pos": 12779947,
      "category": ["Health", "Autoimmune"],
      "gene": "CD226",
      "trait": "Type 1 Diabetes & Autoimmune Risk",
      "risk_model": {"type": "allele_dose", "risk_allele": "T", "per_allele_or": 1.18},
      "interpretation": {"plain_language": "CD226 variant associated with type 1 diabetes and other autoimmune conditions.", "limitations": ["One of many autoimmune risk variants"]},
      "evidence": [{"pmid": "18978792", "study_type": "GWAS", "n": 7500, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs17696736",
      "chr": "12",
      "pos": 56482070,
      "category": ["Health", "Autoimmune"],
      "gene": "NAA25",
      "trait": "Type 1 Diabetes Risk",
      "risk_model": {"type": "allele_dose", "risk_allele": "G", "per_allele_or": 1.16},
      "interpretation": {"plain_language": "NAA25 region variant contributing to type 1 diabetes susceptibility.", "limitations": ["One of many T1D risk variants"]},
      "evidence": [{"pmid": "17554260", "study_type": "GWAS", "n": 5000, "replicated": true}],
      "confidence": "Moderate"
    },
    {
      "rsid": "rs3757247",
      "chr": "6",
      "pos": 90976768,
      "category": ["Health", "Autoimmune"],
      "gene": "BACH2",
      "trait": "Systemic Lupus Erythematosus Risk",
      "risk_model": {"type": "allele_dose", "risk_allele": "T", "per_allele_or": 1.35},
      "interpretation": {"plain_language": "BACH2 variant associated with systemic lupus erythematosus and other autoimmune conditions.", "limitations": ["Lupus is multifactorial", "Sun protection important"]},
      "evidence": [{"pmid": "26432863", "study_type": "GWAS", "n": 8000, "replicated": true}],
      "confidence": "Moderate"
    },
    {
      "rsid": "rs1800896",
      "chr": "1",
      "pos": 206946897,
      "category": ["Health", "Inflammatory"],
      "gene": "IL10",
      "trait": "Immune Regulation (IL-10 -1082)",
      "risk_model": {"type": "allele_dose", "risk_allele": "G", "per_allele_or": 1.2},
      "interpretation": {"plain_language": "IL-10 promoter variant affecting anti-inflammatory cytokine production.", "limitations": ["IL-10 is generally anti-inflammatory", "Complex effects on immune function"]},
      "evidence": [{"pmid": "9399889", "study_type": "Association study", "n": 500, "replicated": true}],
      "confidence": "Moderate"
    },
    {
      "rsid": "rs361525",
      "chr": "6",
      "pos": 31575567,
      "category": ["Health", "Autoimmune"],
      "gene": "TNF",
      "trait": "Psoriasis Risk (TNF-alpha)",
      "risk_model": {"type": "allele_dose", "risk_allele": "A", "per_allele_or": 1.5},
      "interpretation": {"plain_language": "TNF-alpha variant associated with psoriasis susceptibility.", "limitations": ["TNF inhibitors are effective psoriasis treatment"]},
      "evidence": [{"pmid": "8841195", "study_type": "Association study", "n": 300, "replicated": true}],
      "confidence": "Moderate"
    },
    {
      "rsid": "rs6679677",
      "chr": "1",
      "pos": 114303808,
      "category": ["Health", "Autoimmune"],
      "gene": "PTPN22",
      "trait": "Rheumatoid Arthritis Risk",
      "risk_model": {"type": "allele_dose", "risk_allele": "A", "per_allele_or": 1.75},
      "interpretation": {"plain_language": "PTPN22 region variant associated with rheumatoid arthritis and other autoimmune diseases.", "limitations": ["Early treatment improves outcomes"]},
      "evidence": [{"pmid": "14872033", "study_type": "GWAS", "n": 3000, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs2237892",
      "chr": "11",
      "pos": 2796327,
      "category": ["Health", "Metabolic"],
      "gene": "KCNQ1",
      "trait": "Type 2 Diabetes Risk",
      "risk_model": {"type": "allele_dose", "risk_allele": "C", "per_allele_or": 1.4},
      "interpretation": {"plain_language": "KCNQ1 potassium channel variant with strong diabetes association, particularly in East Asian populations.", "limitations": ["Effect size varies by ancestry"]},
      "evidence": [{"pmid": "18711367", "study_type": "GWAS", "n": 5000, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs571312",
      "chr": "18",
      "pos": 60186945,
      "category": ["Health", "Metabolic"],
      "gene": "MC4R",
      "trait": "Obesity Risk",
      "risk_model": {"type": "allele_dose", "risk_allele": "A", "per_allele_or": 1.22},
      "interpretation": {"plain_language": "Additional MC4R variant contributing to obesity susceptibility through appetite dysregulation.", "limitations": ["Weight management effective regardless of genotype"]},
      "evidence": [{"pmid": "18454148", "study_type": "GWAS", "n": 16876, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs1801260",
      "chr": "4",
      "pos": 56338932,
      "category": ["Traits", "Behavioral"],
      "gene": "CLOCK",
      "trait": "Circadian Rhythm & Metabolism",
      "risk_model": {"type": "genotype_category", "categories": {"CC": {"label": "Associated with evening chronotype"}, "CT": {"label": "Intermediate"}, "TT": {"label": "Morning chronotype tendency"}}},
      "interpretation": {"plain_language": "CLOCK gene variant affecting circadian rhythm and metabolic regulation. Associated with evening preference and weight gain.", "limitations": ["Sleep hygiene more important than genetics", "Behavior can override genetic tendencies"]},
      "evidence": [{"pmid": "18463155", "study_type": "Association study", "n": 500, "replicated": true}],
      "confidence": "Low"
    },
    {
      "rsid": "rs4994",
      "chr": "8",
      "pos": 37823798,
      "category": ["Health", "Metabolic"],
      "gene": "ADRB3",
      "trait": "Weight Loss Response (Trp64Arg)",
      "risk_model": {"type": "genotype_category", "categories": {"CC": {"label": "Arg64 - may have reduced thermogenesis"}, "TC": {"label": "Intermediate"}, "TT": {"label": "Trp64 - normal thermogenesis"}}},
      "interpretation": {"plain_language": "Beta-3 adrenergic receptor variant potentially affecting thermogenesis and weight loss response.", "limitations": ["Effect size modest", "Exercise and diet more important"]},
      "evidence": [{"pmid": "9841666", "study_type": "Association study", "n": 500, "replicated": true}],
      "confidence": "Low"
    },
    {
      "rsid": "rs1800206",
      "chr": "22",
      "pos": 46602463,
      "category": ["Health", "Nutrigenomics"],
      "gene": "PPARA",
      "trait": "Lipid Response to Diet (L162V)",
      "risk_model": {"type": "genotype_category", "categories": {"CC": {"label": "Val162 - may respond better to Mediterranean diet"}, "CG": {"label": "Intermediate"}, "GG": {"label": "Leu162 - reference"}}},
      "interpretation": {"plain_language": "PPAR-alpha variant affecting response to dietary fat and potentially fibrate medications.", "limitations": ["Gene-diet interaction studies limited"]},
      "evidence": [{"pmid": "15556289", "study_type": "Intervention study", "n": 200, "replicated": true}],
      "confidence": "Low"
    },
    {
      "rsid": "rs3892097",
      "chr": "22",
      "pos": 42524947,
      "category": ["Health", "Pharmacogenomics"],
      "gene": "CYP2D6",
      "trait": "Drug Metabolism (CYP2D6*4)",
      "risk_model": {"type": "genotype_category", "categories": {"GG": {"label": "Normal metabolizer"}, "GA": {"label": "Intermediate metabolizer"}, "AA": {"label": "Poor metabolizer - nonfunctional CYP2D6"}}},
      "interpretation": {"plain_language": "CYP2D6*4 is the most common nonfunctional allele in Europeans. Poor metabolizers have significantly altered drug responses.", "limitations": ["Full CYP2D6 phenotyping requires multiple variants", "CNV assessment important"]},
      "evidence": [{"pmid": "23486447", "study_type": "Clinical guidelines", "n": 50000, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs4986893",
      "chr": "10",
      "pos": 96540410,
      "category": ["Health", "Pharmacogenomics"],
      "gene": "CYP2C19",
      "trait": "Drug Metabolism (CYP2C19*3)",
      "risk_model": {"type": "genotype_category", "categories": {"GG": {"label": "Normal metabolizer"}, "GA": {"label": "Intermediate metabolizer"}, "AA": {"label": "Poor metabolizer"}}},
      "interpretation": {"plain_language": "CYP2C19*3 is a loss-of-function variant more common in Asian populations.", "limitations": ["Consider with *2 status for overall phenotype"]},
      "evidence": [{"pmid": "20801498", "study_type": "Meta-analysis", "n": 11959, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs28399504",
      "chr": "22",
      "pos": 42526763,
      "category": ["Health", "Pharmacogenomics"],
      "gene": "CYP2D6",
      "trait": "Drug Metabolism (CYP2D6*4)",
      "risk_model": {"type": "genotype_category", "categories": {"GG": {"label": "Normal"}, "GA": {"label": "Intermediate"}, "AA": {"label": "Reduced function"}}},
      "interpretation": {"plain_language": "Additional CYP2D6 variant contributing to metabolizer status.", "limitations": ["Part of comprehensive CYP2D6 assessment"]},
      "evidence": [{"pmid": "23486447", "study_type": "Clinical guidelines", "n": 50000, "replicated": true}],
      "confidence": "Moderate"
    },
    {
      "rsid": "rs1799931",
      "chr": "8",
      "pos": 18258581,
      "category": ["Health", "Pharmacogenomics"],
      "gene": "NAT2",
      "trait": "Drug Metabolism (NAT2 G590A)",
      "risk_model": {"type": "genotype_category", "categories": {"GG": {"label": "Rapid acetylator"}, "GA": {"label": "Intermediate acetylator"}, "AA": {"label": "Slow acetylator"}}},
      "interpretation": {"plain_language": "NAT2 variant affecting acetylator status. Slow acetylators have increased risk of isoniazid-induced hepatotoxicity and may require dose adjustment.", "limitations": ["Multiple NAT2 SNPs determine phenotype"]},
      "evidence": [{"pmid": "10912058", "study_type": "Association study", "n": 1000, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs1801280",
      "chr": "8",
      "pos": 18257854,
      "category": ["Health", "Pharmacogenomics"],
      "gene": "NAT2",
      "trait": "Drug Metabolism (NAT2 T341C/I114T)",
      "risk_model": {"type": "genotype_category", "categories": {"TT": {"label": "Rapid acetylator"}, "TC": {"label": "Intermediate acetylator"}, "CC": {"label": "Slow acetylator"}}},
      "interpretation": {"plain_language": "NAT2 variant contributing to acetylator phenotype. Affects metabolism of isoniazid, sulfonamides, hydralazine, and caffeine.", "limitations": ["Combined with other NAT2 variants for phenotype"]},
      "evidence": [{"pmid": "10912058", "study_type": "Association study", "n": 1000, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs1142345",
      "chr": "6",
      "pos": 18130687,
      "category": ["Health", "Pharmacogenomics"],
      "gene": "TPMT",
      "trait": "Thiopurine Toxicity Risk (TPMT*3C)",
      "risk_model": {"type": "genotype_category", "categories": {"AA": {"label": "Normal activity"}, "AC": {"label": "Intermediate activity - dose reduction needed"}, "CC": {"label": "Deficient - CRITICAL toxicity risk"}}},
      "interpretation": {"plain_language": "TPMT*3C variant causing enzyme deficiency. CRITICAL: Deficient individuals at severe risk of life-threatening myelosuppression from thiopurines.", "limitations": ["MANDATORY testing before thiopurine prescribing"]},
      "evidence": [{"pmid": "23422873", "study_type": "Clinical guidelines", "n": 100000, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs3745274",
      "chr": "19",
      "pos": 41512841,
      "category": ["Health", "Pharmacogenomics"],
      "gene": "CYP2B6",
      "trait": "Drug Metabolism (CYP2B6*6)",
      "risk_model": {"type": "genotype_category", "categories": {"GG": {"label": "Normal metabolizer"}, "GT": {"label": "Intermediate metabolizer"}, "TT": {"label": "Poor metabolizer"}}},
      "interpretation": {"plain_language": "CYP2B6*6 affects metabolism of efavirenz, nevirapine, methadone, and bupropion. Poor metabolizers may have higher drug levels and increased side effects.", "limitations": ["Important for HIV antiretroviral therapy", "Efavirenz CNS side effects more common in poor metabolizers"]},
      "evidence": [{"pmid": "14681345", "study_type": "Association study", "n": 500, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs4149015",
      "chr": "12",
      "pos": 21198555,
      "category": ["Health", "Pharmacogenomics"],
      "gene": "SLCO1B1",
      "trait": "Statin Transport (*1b)",
      "risk_model": {"type": "genotype_category", "categories": {"AA": {"label": "Normal transport"}, "AG": {"label": "Intermediate"}, "GG": {"label": "Reduced transport"}}},
      "interpretation": {"plain_language": "SLCO1B1*1b variant affecting hepatic statin uptake.", "limitations": ["Combined effect with *5 determines overall function"]},
      "evidence": [{"pmid": "18650507", "study_type": "GWAS", "n": 300000, "replicated": true}],
      "confidence": "Moderate"
    },
    {
      "rsid": "rs2032582",
      "chr": "7",
      "pos": 87160618,
      "category": ["Health", "Pharmacogenomics"],
      "gene": "ABCB1",
      "trait": "Drug Transport (P-glycoprotein G2677T/A)",
      "risk_model": {"type": "genotype_category", "categories": {"GG": {"label": "Normal P-gp function"}, "GT": {"label": "Intermediate"}, "TT": {"label": "Reduced P-gp function"}}},
      "interpretation": {"plain_language": "P-glycoprotein variant affecting drug efflux. May affect levels of digoxin, immunosuppressants, and many other drugs.", "limitations": ["Clinical significance varies by drug"]},
      "evidence": [{"pmid": "15087604", "study_type": "Meta-analysis", "n": 3000, "replicated": true}],
      "confidence": "Low"
    },
    {
      "rsid": "rs5030656",
      "chr": "22",
      "pos": 42523569,
      "category": ["Health", "Pharmacogenomics"],
      "gene": "CYP2D6",
      "trait": "Drug Metabolism (CYP2D6*9)",
      "risk_model": {"type": "genotype_category", "categories": {"wt/wt": {"label": "Normal"}, "wt/del": {"label": "Intermediate"}, "del/del": {"label": "Reduced function"}}},
      "interpretation": {"plain_language": "CYP2D6*9 is a reduced function allele.", "limitations": ["Part of comprehensive CYP2D6 assessment"]},
      "evidence": [{"pmid": "23486447", "study_type": "Clinical guidelines", "n": 50000, "replicated": true}],
      "confidence": "Moderate"
    },
    {
      "rsid": "rs13281615",
      "chr": "8",
      "pos": 128414868,
      "category": ["Health", "Cancer"],
      "gene": "8q24",
      "trait": "Breast Cancer Risk (8q24)",
      "risk_model": {"type": "allele_dose", "risk_allele": "G", "per_allele_or": 1.13},
      "interpretation": {"plain_language": "8q24 region variant associated with breast cancer risk.", "limitations": ["Effect size modest", "Part of polygenic risk"]},
      "evidence": [{"pmid": "17529967", "study_type": "GWAS", "n": 4398, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs16901979",
      "chr": "8",
      "pos": 128194098,
      "category": ["Health", "Cancer"],
      "gene": "8q24",
      "trait": "Prostate Cancer Risk (8q24 region 2)",
      "risk_model": {"type": "allele_dose", "risk_allele": "A", "per_allele_or": 1.52},
      "interpretation": {"plain_language": "Independent 8q24 prostate cancer risk variant.", "limitations": ["Part of 8q24 prostate cancer risk region"]},
      "evidence": [{"pmid": "17401366", "study_type": "GWAS", "n": 4000, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs3802842",
      "chr": "11",
      "pos": 111171709,
      "category": ["Health", "Cancer"],
      "gene": "COLCA1/COLCA2",
      "trait": "Colorectal Cancer Risk (11q23)",
      "risk_model": {"type": "allele_dose", "risk_allele": "C", "per_allele_or": 1.22},
      "interpretation": {"plain_language": "11q23 variant associated with colorectal cancer risk.", "limitations": ["Screening colonoscopy important regardless"]},
      "evidence": [{"pmid": "18372905", "study_type": "GWAS", "n": 7000, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs4488809",
      "chr": "3",
      "pos": 189508471,
      "category": ["Health", "Cancer"],
      "gene": "TP63",
      "trait": "Bladder Cancer Risk",
      "risk_model": {"type": "allele_dose", "risk_allele": "T", "per_allele_or": 1.37},
      "interpretation": {"plain_language": "TP63 variant associated with bladder cancer susceptibility.", "limitations": ["Smoking cessation most important prevention"]},
      "evidence": [{"pmid": "20972438", "study_type": "GWAS", "n": 10000, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs710521",
      "chr": "3",
      "pos": 189551923,
      "category": ["Health", "Cancer"],
      "gene": "TP63",
      "trait": "Bladder Cancer Risk",
      "risk_model": {"type": "allele_dose", "risk_allele": "A", "per_allele_or": 1.25},
      "interpretation": {"plain_language": "Additional bladder cancer susceptibility variant in TP63 region.", "limitations": ["Avoid smoking to reduce risk"]},
      "evidence": [{"pmid": "18438406", "study_type": "GWAS", "n": 5000, "replicated": true}],
      "confidence": "Moderate"
    },
    {
      "rsid": "rs2428913",
      "chr": "9",
      "pos": 21860461,
      "category": ["Health", "Cancer"],
      "gene": "MTAP",
      "trait": "Melanoma Risk",
      "risk_model": {"type": "allele_dose", "risk_allele": "C", "per_allele_or": 1.31},
      "interpretation": {"plain_language": "MTAP region variant associated with melanoma susceptibility.", "limitations": ["Sun protection is key prevention"]},
      "evidence": [{"pmid": "18488026", "study_type": "GWAS", "n": 5000, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs1015362",
      "chr": "20",
      "pos": 33579898,
      "category": ["Health", "Cancer", "Traits"],
      "gene": "ASIP",
      "trait": "Melanoma Risk & Pigmentation",
      "risk_model": {"type": "allele_dose", "risk_allele": "A", "per_allele_or": 1.27},
      "interpretation": {"plain_language": "Agouti signaling protein variant affecting pigmentation and melanoma risk.", "limitations": ["Sun protection critical"]},
      "evidence": [{"pmid": "18488026", "study_type": "GWAS", "n": 5000, "replicated": true}],
      "confidence": "Moderate"
    },
    {
      "rsid": "rs4779584",
      "chr": "15",
      "pos": 32994756,
      "category": ["Health", "Cancer"],
      "gene": "GREM1",
      "trait": "Colorectal Cancer Risk",
      "risk_model": {"type": "allele_dose", "risk_allele": "T", "per_allele_or": 1.26},
      "interpretation": {"plain_language": "GREM1 region variant associated with colorectal cancer risk.", "limitations": ["Colonoscopy screening per guidelines"]},
      "evidence": [{"pmid": "18372901", "study_type": "GWAS", "n": 7000, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs1799950",
      "chr": "17",
      "pos": 41276113,
      "category": ["Health", "Cancer"],
      "gene": "BRCA1",
      "trait": "Breast Cancer Risk (Q356R)",
      "risk_model": {"type": "allele_dose", "risk_allele": "A", "per_allele_or": 1.2},
      "interpretation": {"plain_language": "BRCA1 missense variant with modest association to breast cancer risk. This is NOT a pathogenic BRCA1 mutation.", "limitations": ["Not equivalent to pathogenic BRCA1 mutations", "Standard screening appropriate"]},
      "evidence": [{"pmid": "17305478", "study_type": "Association study", "n": 3000, "replicated": true}],
      "confidence": "Moderate"
    },
    {
      "rsid": "rs1801320",
      "chr": "15",
      "pos": 40994711,
      "category": ["Health", "Cancer"],
      "gene": "RAD51",
      "trait": "DNA Repair Capacity",
      "risk_model": {"type": "allele_dose", "risk_allele": "C", "per_allele_or": 1.3},
      "interpretation": {"plain_language": "RAD51 variant affecting DNA double-strand break repair. May interact with BRCA2 mutations.", "limitations": ["Clinical significance limited for non-BRCA carriers"]},
      "evidence": [{"pmid": "15956392", "study_type": "Association study", "n": 500, "replicated": true}],
      "confidence": "Low"
    },
    {
      "rsid": "rs76151636",
      "chr": "7",
      "pos": 117199645,
      "category": ["Health", "Carrier Status"],
      "gene": "CFTR",
      "trait": "Cystic Fibrosis Carrier (F508del)",
      "risk_model": {"type": "genotype_category", "categories": {"II": {"label": "Non-carrier"}, "ID": {"label": "Carrier - healthy but can pass to children"}, "DD": {"label": "Affected - cystic fibrosis"}}},
      "interpretation": {"plain_language": "F508del is the most common cystic fibrosis mutation (70% of CF alleles). Carriers are healthy but can have affected children if partner is also a carrier.", "limitations": ["Genetic counseling recommended if carrier", "Partner testing important for family planning"]},
      "evidence": [{"pmid": "2475911", "study_type": "Original discovery", "n": 1000, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs80338939",
      "chr": "15",
      "pos": 72346580,
      "category": ["Health", "Carrier Status"],
      "gene": "HEXA",
      "trait": "Tay-Sachs Disease Carrier",
      "risk_model": {"type": "genotype_category", "categories": {"NN": {"label": "Non-carrier"}, "NC": {"label": "Carrier - healthy"}, "CC": {"label": "Affected - Tay-Sachs disease"}}},
      "interpretation": {"plain_language": "Tay-Sachs carrier status. More common in Ashkenazi Jewish and French Canadian populations. Carriers are healthy.", "limitations": ["Carrier screening recommended for at-risk populations", "Partner testing critical before pregnancy"]},
      "evidence": [{"pmid": "11992261", "study_type": "Clinical genetics", "n": 10000, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs28940868",
      "chr": "12",
      "pos": 103234164,
      "category": ["Health", "Carrier Status"],
      "gene": "PAH",
      "trait": "Phenylketonuria (PKU) Carrier",
      "risk_model": {"type": "genotype_category", "categories": {"NN": {"label": "Non-carrier"}, "NC": {"label": "Carrier"}, "CC": {"label": "Affected - PKU"}}},
      "interpretation": {"plain_language": "PKU carrier status. Newborn screening identifies affected infants, who require phenylalanine-restricted diet.", "limitations": ["Newborn screening catches affected individuals"]},
      "evidence": [{"pmid": "20301627", "study_type": "Clinical genetics", "n": 5000, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs113993960",
      "chr": "7",
      "pos": 117227832,
      "category": ["Health", "Carrier Status", "Pharmacogenomics"],
      "gene": "CFTR",
      "trait": "Cystic Fibrosis (G551D) - Ivacaftor Responsive",
      "risk_model": {"type": "genotype_category", "categories": {"GG": {"label": "Non-carrier"}, "GA": {"label": "Carrier"}, "AA": {"label": "Affected"}}},
      "interpretation": {"plain_language": "CFTR G551D is responsive to ivacaftor (Kalydeco). Important pharmacogenomic information for CF treatment.", "limitations": ["Identifies patients who benefit from specific CF modulator therapy"]},
      "evidence": [{"pmid": "21639805", "study_type": "Clinical trial", "n": 200, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs11970176",
      "chr": "14",
      "pos": 94847262,
      "category": ["Health", "Carrier Status"],
      "gene": "SERPINA1",
      "trait": "Alpha-1 Antitrypsin Deficiency (Z allele)",
      "risk_model": {"type": "genotype_category", "categories": {"MM": {"label": "Normal"}, "MZ": {"label": "Carrier - mildly reduced A1AT"}, "ZZ": {"label": "Severe deficiency - COPD/liver disease risk"}}},
      "interpretation": {"plain_language": "Alpha-1 antitrypsin Z allele. ZZ homozygotes have severe deficiency causing early-onset COPD and liver disease. Smoking dramatically accelerates lung damage.", "limitations": ["CRITICAL: ZZ individuals must never smoke", "Augmentation therapy available"]},
      "evidence": [{"pmid": "12765945", "study_type": "Clinical genetics", "n": 10000, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs17580",
      "chr": "14",
      "pos": 94847262,
      "category": ["Health", "Carrier Status"],
      "gene": "SERPINA1",
      "trait": "Alpha-1 Antitrypsin Deficiency (S allele)",
      "risk_model": {"type": "genotype_category", "categories": {"MM": {"label": "Normal"}, "MS": {"label": "Mildly reduced A1AT"}, "SS": {"label": "Moderately reduced A1AT"}}},
      "interpretation": {"plain_language": "A1AT S variant causes milder deficiency than Z. SS or SZ compound heterozygotes may have moderate deficiency.", "limitations": ["Avoid smoking", "SZ compound heterozygotes at intermediate risk"]},
      "evidence": [{"pmid": "12765945", "study_type": "Clinical genetics", "n": 10000, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs74315329",
      "chr": "1",
      "pos": 155205634,
      "category": ["Health", "Carrier Status", "Neurological"],
      "gene": "GBA",
      "trait": "Gaucher Disease Carrier & Parkinson's Risk",
      "risk_model": {"type": "genotype_category", "categories": {"GG": {"label": "Non-carrier"}, "GA": {"label": "Carrier - increased Parkinson's risk"}, "AA": {"label": "Gaucher disease"}}},
      "interpretation": {"plain_language": "GBA N370S is a Gaucher disease mutation. Importantly, carriers have ~5-fold increased Parkinson's disease risk.", "limitations": ["Parkinson's risk significant even for carriers", "Gaucher disease more common in Ashkenazi Jewish population"]},
      "evidence": [{"pmid": "15024688", "study_type": "Association study", "n": 5000, "replicated": true}, {"pmid": "19846850", "study_type": "Meta-analysis", "n": 12000, "replicated": true}],
      "confidence": "High"
    },
    {
      "rsid": "rs76763715",
      "chr": "15",
      "pos": 91350475,
      "category": ["Health", "Carrier Status"],
      "gene": "BLM",
      "trait": "Bloom Syndrome Carrier",
      "risk_model": {"type": "genotype_category", "categories": {"NN": {"label": "Non-carrier"}, "NC": {"label": "Carrier"}, "CC": {"label": "Bloom syndrome"}}},
      "interpretation": {"plain_language": "Bloom syndrome carrier status. Primarily found in Ashkenazi Jewish population. Carriers are healthy.", "limitations": ["Partner testing important for at-risk couples"]},
      "evidence": [{"pmid": "7585968", "study_type": "Clinical genetics", "n": 1000, "replicated": true}],
      "confidence": "High"
    }
  ]
}